[go: up one dir, main page]

DE60026161D1 - Amidin-derivate, ihre herstellung und verwendung als medikamenten - Google Patents

Amidin-derivate, ihre herstellung und verwendung als medikamenten

Info

Publication number
DE60026161D1
DE60026161D1 DE60026161T DE60026161T DE60026161D1 DE 60026161 D1 DE60026161 D1 DE 60026161D1 DE 60026161 T DE60026161 T DE 60026161T DE 60026161 T DE60026161 T DE 60026161T DE 60026161 D1 DE60026161 D1 DE 60026161D1
Authority
DE
Germany
Prior art keywords
medicaments
preparation
sup
sub
amidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60026161T
Other languages
English (en)
Other versions
DE60026161T2 (de
Inventor
De Lassauniere Pierre Chabrier
Jeremiah Harnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of DE60026161D1 publication Critical patent/DE60026161D1/de
Publication of DE60026161T2 publication Critical patent/DE60026161T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
DE60026161T 1999-11-16 2000-11-15 Amidin-derivate, ihre herstellung und verwendung als medikamente Expired - Fee Related DE60026161T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9914334 1999-11-16
FR9914334A FR2801053B1 (fr) 1999-11-16 1999-11-16 Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
PCT/FR2000/003168 WO2001036407A1 (fr) 1999-11-16 2000-11-15 Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments

Publications (2)

Publication Number Publication Date
DE60026161D1 true DE60026161D1 (de) 2006-04-27
DE60026161T2 DE60026161T2 (de) 2006-11-16

Family

ID=9552131

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60026161T Expired - Fee Related DE60026161T2 (de) 1999-11-16 2000-11-15 Amidin-derivate, ihre herstellung und verwendung als medikamente

Country Status (14)

Country Link
US (2) US6770669B1 (de)
EP (1) EP1233957B1 (de)
JP (1) JP2003514811A (de)
AT (1) ATE318265T1 (de)
AU (1) AU1712601A (de)
CA (1) CA2391598A1 (de)
CZ (1) CZ20021645A3 (de)
DE (1) DE60026161T2 (de)
ES (1) ES2258984T3 (de)
FR (1) FR2801053B1 (de)
HU (1) HUP0203557A3 (de)
PL (1) PL355677A1 (de)
RU (1) RU2272807C2 (de)
WO (1) WO2001036407A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801053B1 (fr) * 1999-11-16 2004-06-25 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
RU2260005C2 (ru) 2000-03-16 2005-09-10 Сосьете Де Консей Де Решерш Э Д'Аппликасьон Сьентифик (С.К.Р.А.С.) Производные липоевой кислоты, способ их получения (варианты) и фармацевтическая композиция
DE10162114A1 (de) * 2001-12-12 2003-06-26 Schering Ag Neue Amidin-Derivate und deren Verwendung in Arzneimitteln
WO2008058167A2 (en) * 2006-11-07 2008-05-15 Case Western Reserve University Method for treating disorders associated with complement activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA43318C2 (uk) * 1992-02-05 2001-12-17 Берінгер Інгельхейм Кг Похідні амідину, фармацевтична композиція з антагоністичною по відношенню до лейкотриєну в4 активністю
IL110643A (en) * 1993-08-12 1998-07-15 Astra Ab Amidine derivatives their preparation and pharmaceutical compositions containing them
AU2629795A (en) * 1994-12-12 1996-07-03 Chugai Seiyaku Kabushiki Kaisha Aniline derivative having the effect of inhibiting nitrogen monoxide synthase
AU2978197A (en) * 1996-06-04 1998-01-05 Chugai Seiyaku Kabushiki Kaisha Substituted benzenes having nos inhibitory effects
AUPO252896A0 (en) * 1996-09-24 1996-10-17 Fujisawa Pharmaceutical Co., Ltd. Amidine derivatives
US6335445B1 (en) * 1997-03-24 2002-01-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2761066B1 (fr) * 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2783519B1 (fr) * 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2801053B1 (fr) * 1999-11-16 2004-06-25 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
US6706754B2 (en) * 2000-11-06 2004-03-16 The United States Of America As Represented By The Secretary Of The Army Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Also Published As

Publication number Publication date
EP1233957A1 (de) 2002-08-28
HUP0203557A2 (hu) 2003-03-28
HUP0203557A3 (en) 2005-02-28
US7019025B2 (en) 2006-03-28
US6770669B1 (en) 2004-08-03
ATE318265T1 (de) 2006-03-15
CA2391598A1 (fr) 2001-05-25
RU2272807C2 (ru) 2006-03-27
RU2002115868A (ru) 2004-01-20
US20040225008A1 (en) 2004-11-11
DE60026161T2 (de) 2006-11-16
WO2001036407A1 (fr) 2001-05-25
EP1233957B1 (de) 2006-02-22
JP2003514811A (ja) 2003-04-22
AU1712601A (en) 2001-05-30
CZ20021645A3 (cs) 2002-09-11
FR2801053A1 (fr) 2001-05-18
FR2801053B1 (fr) 2004-06-25
ES2258984T3 (es) 2006-09-16
PL355677A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
DE60129210D1 (de) Zyklische amid-derivate
DE69736642D1 (de) Heterocyclische Verbindungen, ihre Herstellung und Verwendung
ES2121441T3 (es) Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco
DE60118225D1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
EP1190710A4 (de) Vorbeugende oder therapeutische medikamente für diabetes
CA2336412A1 (en) Medicament for treatment of diabetes
EP1775289A4 (de) Neue imidazolidinderivate
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
ATE450496T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
AU2001269540A1 (en) Serotonin reuptake inhibitors
YU33202A (sh) Jedinjenja o-etar oksima i fungicidi za primenu u zemljoradnji i vrtlarstvu
DE60026161D1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
MX9206930A (es) Nuevos compuestos
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
MXPA04001171A (es) Compuestos policiclicos condensados.
BR0207966A (pt) Composição farmacêutica contendo derivados 1,3-tiazina
DE60119383D1 (de) Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
PT1351942E (pt) Novos derivados da 2,3-benzodiazepina e composicoes farmaceuticas contendo os mesmos como o ingrediente activo
ATE434615T1 (de) Farnesyltransferase hemmende benzoheterocyclische derivate
AU2001295601A1 (en) N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists
TH21054A (th) อนุพันธ์ซัลโพแนมีดของแอโซโลน
DK0717990T3 (da) Præparat til behandling af lægemiddelafhængighed
TH37487A (th) อนุพันธ์กรดเฮกชาโนอิคตัวใหม่

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee